Anti –Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis

This study aimed to evaluate the cost-effectiveness of anti –vascular endothelial growth factor drugs (anti-VEGFs) compared with panretinal photocoagulation (PRP) for treating proliferative diabetic retinopathy (PDR) in the United Kingdom.

Source: Value in Health - March 26, 2024 Category: International Medicine & Public Health Authors: Matthew Walton, Laura Bojke, Mark Simmonds, Ruth Walker, Alexis Llewellyn, Helen Fulbright, Sofia Dias, Lesley A. Stewart, Tom Rush, David H. Steel, John G. Lawrenson, Tunde Peto, Robert Hodgson Tags: Economic Evaluation Source Type: research